MedPath

Supervision of exercises for improving compliance and reducing the side effects of prostate cancer treatment

Phase 3
Conditions
Health Condition 1: C61- Malignant neoplasm of prostate
Registration Number
CTRI/2024/03/064558
Lead Sponsor
Tata medical center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Participants must have all of the following:

1 Confirmed prostatic carcinoma

2 Will undergo radiation therapy - radical

3 radiation therapy or prostate directed radiation therapy

4 Is on androgen deprivation therapy with either medical or surgical methods and is planned to be on this for a minimum duration of 6 months

5 ECOG Performance status 0-1

6 Signed study specific consent form

7 Patient willing and reliable for follow-up

Exclusion Criteria

1.ECOG Performance status 2 or more

2.Limitation in mobility and/or comorbidities that will prevent them from complying to exercise requirements

3.Unable to follow up or poor logistic or social support

4.Deemed to be at high risk of harm due to the presence of lytic bone metastases

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath